BIO-TECHNE Corp
For the period ended Jun 30, 2026. Filed Aug 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 10. Directors, Executive Officers
The information required to be included in Item 10 will be included in our proxy statement for our 2026 Annual Meeting of Shareholders (“2026 Proxy Statement”) or Form 10-K/A, which we intend to file with the SEC within 120 days after the close of our fiscal 2026 year, and is incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.